Clinical Trial: Long-term Outcomes of Patients With Primary Amyloidosis After Stem Cell Transplantation
Study Status: Completed
Recruit Status: Completed
Study Type: Observational
Official Title: Reporting of Amyloidosis Stem Cell Transplantation Outcomes
Brief Summary: This study examines the value of stem cell transplantation in managing light chain amyloidisis.
Detailed Summary:
- How does age at diagnosis affect prognosis in primary amyloidosis?
- How do lab values at diagnosis such as Creatinine, AST/ALT, total serum protein, serum gamma globulin/immunoglobulin levels affect prognosis in primary amyloidosis?
- How does degree of organ involvement/number of organs involved affect prognosis in primary amyloidosis?
- How does initial treatment affect prognosis in primary amyloidosis?
4. How do the specifics the stem cell transplant protocol affect prognosis in primary amyloidosis?
Sponsor: Mayo Clinic
Current Primary Outcome: Survival [ Time Frame: up to 8 years ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Mayo Clinic
Dates:
Date Received: March 15, 2012
Date Started: June 2011
Date Completion:
Last Updated: January 20, 2014
Last Verified: January 2014